Altered plasma visfatin levels and insulin resistance in patients with Alzheimer’s disease

Role of peroxisome proliferator–activated receptor-gamma activation on visfatin, advanced glycation end products, and renal oxidative stress in obesity-induced type 2 diabetes mellitus

(2018) A Tabassum et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

Adiponectin modulates synaptic plasticity in hippocampal dentate gyrus

(2018) Farideh Pousti et al.   NEUROSCIENCE LETTERS

Visfatin Triggers Anorexia and Body Weight Loss through Regulating the Inflammatory Response in the Hypothalamic Microglia

(2017) Thai Hien Tu et al.   MEDIATORS OF INFLAMMATION

Intracerebroventricular administration of adiponectin attenuates streptozotocin-induced memory impairment in rats

(2017) R Mazrooie et al.   Physiology International

The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling

(2016) Aleksander J. Owczarek et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Serum high-molecular-weight adiponectin level and incident dementia in patients with vascular risk factors

(2015) K. Kitagawa et al.   EUROPEAN JOURNAL OF NEUROLOGY

Nampt/PBEF/Visfatin Exerts Neuroprotective Effects Against Ischemia/Reperfusion Injury via Modulation of Bax/Bcl-2 Ratio and Prevention of Caspase-3 Activation

(2015) Sohaila Erfani et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Correlations of serum visfatin and metabolisms of glucose and lipid in women with gestational diabetes mellitus

(2015) Zhaoxia Liang et al.   Journal of Diabetes Investigation

Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle–Aged Adults at Risk for Alzheimer Disease

(2015) Auriel A. Willette et al.   JAMA Neurology

How does brain insulin resistance develop in Alzheimer's disease?

(2014) Fernanda G. De Felice et al.   Alzheimers & Dementia

Obesity and dementia: Adipokines interact with the brain

(2014) Ilse A.C. Arnoldussen et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Adipokines: a link between obesity and dementia?

(2014) Amanda J Kiliaan et al.   LANCET NEUROLOGY

Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease

(2012) Antonio L. Teixeira et al.   NEUROMOLECULAR MEDICINE

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Clifford R. Jack et al.   Alzheimers & Dementia

Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway

(2011) Pei Wang et al.   ANNALS OF NEUROLOGY

Insulin resistance and Alzheimer's disease

(2011) Suzanne M. De La Monte   BMB Reports

Visfatin induces neurite outgrowth in PC12 cells via ERK1/2 signaling pathway

(2011) Young-Soon Kang et al.   NEUROSCIENCE LETTERS

Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer’s disease

(2010) K. Une et al.   EUROPEAN JOURNAL OF NEUROLOGY

Neuronal Protective Role of PBEF in a Mouse Model of Cerebral Ischemia

(2010) Weiping Zhang et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

The Role of Adipose Tissue and Adipokines in Obesity-Related Inflammatory Diseases

(2010) Carmela Rita Balistreri et al.   MEDIATORS OF INFLAMMATION

Insulin metabolism and the risk of Alzheimer disease: The Rotterdam Study

(2010) E. M. C. Schrijvers et al.   NEUROLOGY

Serum leptin level and cognition in the elderly: Findings from the Health ABC Study

(2008) Karen F. Holden et al.   NEUROBIOLOGY OF AGING